Health Products

Auro Pharma Losartan product recall (2021-10-01)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

Auro-Losartan 25 mg Tablet

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDIN, NPN, DIN-HIMDosage formStrength
AEJ5020001A, AEJ5020002A, AEJ5020003AAuro-Losartan 50 mg Tablet
Recalling Firm
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
Marketing Authorization Holder
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
DIN 02403331TabletLosartan Potassium 50 mg
AEJ1020001A, AEJ1020002A, AEJ1020003AAuro-Losartan 100 mg Tablet
Recalling Firm
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
Marketing Authorization Holder
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
DIN 02403358TabletLosartan Potassium 100 mg
AEJ2520001AAuro-Losartan 25 mg Tablet
Recalling Firm
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
Marketing Authorization Holder
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
DIN 02403323TabletLosartan Potassium 25 mg

Introduction

  1. Auro-Losartan 25 mg Tablet
  2. Auro-Losartan 50 mg Tablet
  3. Auro-Losartan 100 mg Tablet

Reason

Presence of impurity (5-(4 '- ((5 - (Azidomethyl) -2-butyl-4-chloro-1H-imidazol-1-yl) methyl)-[1,1' - biphenyl] - 2-yl) - 1H-tetrazole above the acceptable concentration limit in affected lots.

For more information

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime